130.43
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$128.22
Offen:
$130.14
24-Stunden-Volumen:
722.87K
Relative Volume:
1.02
Marktkapitalisierung:
$5.53B
Einnahmen:
$2.81B
Nettoeinkommen (Verlust:
$-294.68M
KGV:
-5.7182
EPS:
-22.8098
Netto-Cashflow:
$232.59M
1W Leistung:
+4.24%
1M Leistung:
+1.90%
6M Leistung:
+0.16%
1J Leistung:
+5.29%
Teleflex Incorporated Stock (TFX) Company Profile
Firmenname
Teleflex Incorporated
Sektor
Telefon
610-225-6800
Adresse
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX vs ISRG, BDX, RMD, ALC, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TFX
Teleflex Incorporated
|
130.43 | 5.53B | 2.81B | -294.68M | 232.59M | -22.81 |
|
ISRG
Intuitive Surgical Inc
|
426.70 | 150.74B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
191.75 | 52.23B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
238.97 | 33.61B | 5.54B | 1.52B | 1.74B | 10.37 |
|
ALC
Alcon Inc
|
66.18 | 31.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
35.96 | 31.55B | 29.14B | 1.07B | 1.05B | 1.1956 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-28 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-07-28 | Eingeleitet | UBS | Neutral |
| 2026-07-09 | Eingeleitet | BMO Capital Markets | Outperform |
| 2026-06-08 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2026-05-08 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2026-04-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-03-27 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2026-01-27 | Hochstufung | Needham | Hold → Buy |
| 2025-03-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-02-28 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-02-28 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-02-27 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-07-01 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-12-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-21 | Herabstufung | Needham | Buy → Hold |
| 2023-05-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-04-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-10-26 | Eingeleitet | Mizuho | Neutral |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-29 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-09-07 | Fortgesetzt | Raymond James | Outperform |
| 2021-07-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-01-06 | Bestätigt | Needham | Buy |
| 2020-11-02 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-06-11 | Eingeleitet | Wells Fargo | Outperform |
| 2019-04-24 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-02-22 | Bestätigt | Needham | Strong Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-09-10 | Hochstufung | Needham | Buy → Strong Buy |
| 2018-08-03 | Bestätigt | Needham | Buy |
| 2018-05-14 | Bestätigt | Needham | Buy |
| 2018-05-04 | Bestätigt | Needham | Buy |
| 2018-04-04 | Eingeleitet | Goldman | Neutral |
| 2017-11-10 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-11-03 | Bestätigt | Needham | Buy |
| 2017-09-08 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2017-09-06 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-06 | Bestätigt | Needham | Buy |
| 2017-03-07 | Eingeleitet | Needham | Buy |
| 2017-01-06 | Hochstufung | Jefferies | Hold → Buy |
| 2016-07-12 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
Alle ansehen
Teleflex Incorporated Aktie (TFX) Neueste Nachrichten
Teleflex Inc. stock outperforms competitors despite losses on the day - MarketWatch
Disposable Nasal Airway Tubes Market Forecast to 2035, Driven by Rising Surgical Volumes and Aging Demographics - IndexBox
Balloon Inflation Devices Market To 2035: Minimally Invasive Procedures Fuel GrowthNews and Statistics - IndexBox
Pulmonary Artery Catheters Market Forecast to 2035: Demand to Accelerate on Rising High-Risk Cardiac Procedures - IndexBox
Why Is Teleflex (NYSE:TFX) Drawing Fresh Healthcare Attention? - Kalkine Media
Teleflex completes enrollment in coronary scaffold study By Investing.com - Investing.com Canada
Teleflex completes enrollment in BIOMAG-LL magnesium scaffold study - StreetInsider
102 patients joined a study of longer artery supports designed to be absorbed - Stock Titan
Teleflex Catheters Linked to 70% Lower Infection Hazard - MyChesCo
Epidural Needles Market To 2035: Growth Driven by Rising Obstetric Anesthesia DemandNews and Statistics - IndexBox
Teleflex Incorporated (TFX) Stock forecasts - Yahoo Finance Singapore
China Airway Management Market Forecast to 2033Airway Management Tubes and Intubation Accessories | Revenue, Volume, Pricing, Company Share, and Growth Opportunities - GlobeNewswire Inc.
Teleflex Q3 2026 Earnings Date and Estimates - MarketBeat
Bruker Gains 66.3% in a Year: What's Driving the Rally? - Zacks Investment Research
Full Transcript: Teleflex Q2 2026 Earnings Call - Benzinga
Teleflex Incorporated (TFX) Stock Forecasts - Yahoo Finance
Teleflex Incorporated (TFX) Stock Forecasts - Yahoo! Finance Canada
Reasons to Add Globus Medical Stock to Your Portfolio Now - Zacks Investment Research
Charles River Gains 75.8% in a Year: What's Driving the Rally? - Zacks Investment Research
TFX or SONVY: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Is It Prudent to Add Teleflex Stock to Your Portfolio Now? - Zacks Investment Research
Teleflex Incorporated (NYSE:TFX) Stock Now Rated "Moderate Buy" by Wall Street Brokerages - MarketBeat
Teleflex Inc. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific's MedSurg Diversification Bolsters Growth Prospects - Zacks Investment Research
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology - Business Wire
Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock? - finance.yahoo.com
Teleflex Incorporated (TFX) stock price, news, quote and history - Yahoo Finance Singapore
Teleflex stock falls 2.52 percent after quarterly results - ad-hoc-news.de
Teleflex Incorporated (TFX) Stock forecasts - Yahoo Finance Singapore
Teleflex Incorporated (TFX) Stock Forecasts - finance.yahoo.com
Teleflex Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now - Zacks Investment Research
Teleflex stock holds near USD 125 as target cuts sharpen the debate - AD HOC NEWS
Teleflex Incorporated (TFX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is This the Right Time to Add DGX Stock to Your Portfolio? - Zacks Investment Research
Corient Private Wealth LP Has $2.92 Million Holdings in Teleflex Incorporated $TFX - MarketBeat
Teleflex Incorporated (TFX) Stock Analysis: Potential 23% Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Bank of America Corp DE Invests $61.16 Million in Teleflex Incorporated $TFX - MarketBeat
Teleflex (TFX) Adds A Board Veteran, Is The 19% Undervalued View Enough? - Yahoo Finance
Teleflex Stock Price Forecast. Should You Buy TFX? - StockInvest.us
Teleflex Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Teleflex Incorporated (TFX) Stock Forecasts - Yahoo Finance
Teleflex Study Backs Radial Access for Iliac Stenting - MyChesCo
Teleflex Inc. stock dips after strong Q2 earnings and Hold consensus - ad-hoc-news.de
Teleflex stock heads into the open after a 2.7% drop - ad-hoc-news.de
Teleflex Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Director Sean Salmon receives Teleflex (NYSE: TFX) stock and options - Stock Titan
New Teleflex (NYSE: TFX) director Sean Salmon reports no stock stake - Stock Titan
Teleflex (NYSE: TFX) Welcomes Sean M. Salmon to Board, Bringing Expertise from $12.5B Medtronic Cardiovascular Portfolio - Kalkine Media
Teleflex stock heads into the open after a 3.3 percent weekly gain - ad-hoc-news.de
Finanzdaten der Teleflex Incorporated-Aktie (TFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):